Vivoryon Therapeutics N.V. filed its Annual on Apr 19, 2023 for the period ending Dec 31, 2022. In this report its auditor, KPMG LLP - Klynveld Peat Marwick Goerdeler, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.92 EUR | -4.48% |
|
-22.89% | -76.41% |
23/05 | Transcript : Vivoryon Therapeutics N.V., Q1 2024 Earnings Call, May 23, 2024 | |
24/04 | Transcript : Vivoryon Therapeutics N.V., 2023 Earnings Call, Apr 24, 2024 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-76.41% | 56.18M | |
+38.66% | 52.85B | |
-7.81% | 38.87B | |
+35.51% | 38.24B | |
-10.77% | 26.79B | |
+11.77% | 26.16B | |
-17.82% | 19.9B | |
+35.09% | 13.18B | |
+29.17% | 12.24B | |
-3.05% | 11.79B |
- Stock Market
- Equities
- VVY Stock
- News Vivoryon Therapeutics N.V.
- Vivoryon Therapeutics N.V. Auditor Raises 'Going Concern' Doubt